Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Truls Sylvan Ingebrigtsen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Thorax|September 5, 2019
β<sub>2</sub>-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort studyTruls Sylvan Ingebrigtsen, Jørgen Vestbo, Line Rode, et al.
Respiratory Medicine|October 4, 2016
Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPDSandra Søgaard Tøttenborg, Peter Lange, Søren Paaske Johnsen, et al.
JAMA|June 13, 2013
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseMette Thomsen, Truls Sylvan Ingebrigtsen, Jacob Louis Marott, et al.
American Journal of Respiratory and Critical Care Medicine|September 22, 2012
Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationPeter Lange, Jacob Louis Marott, Jørgen Vestbo, et al.
The Lancet Regional Health. Europe|November 29, 2023
Impact of the metabolic syndrome on cardiopulmonary morbidity and mortality in individuals with lung function impairment: a prospective cohort study of the Danish general populationJacob Louis Marott, Truls Sylvan Ingebrigtsen, Yunus Çolak, et al.
BMJ Open Respiratory Research|June 11, 2019
COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 monthsPradeesh Sivapalan, Truls Sylvan Ingebrigtsen, Daniel Bech Rasmussen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 13, 2023
Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma RegisterMarianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
ERJ Open Research|October 6, 2022
Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma RegisterMarianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
BMJ Open Respiratory Research|September 29, 2023
Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort studyChristian Kjer Heerfordt, Christian Rønn, Zitta Barrella Harboe, et al.
Thorax|August 27, 2021
Use of inhaled corticosteroids and risk of acquiring <i>Pseudomonas aeruginosa</i> in patients with chronic obstructive pulmonary diseaseJosefin Eklöf, Truls Sylvan Ingebrigtsen, Rikke Sørensen, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Thorax|September 5, 2019
β<sub>2</sub>-Adrenergic genotypes and risk of severe exacerbations in COPD: a prospective cohort studyTruls Sylvan Ingebrigtsen, Jørgen Vestbo, Line Rode, et al.
Respiratory Medicine|October 4, 2016
Socioeconomic inequalities in adherence to inhaled maintenance medications and clinical prognosis of COPDSandra Søgaard Tøttenborg, Peter Lange, Søren Paaske Johnsen, et al.
JAMA|June 13, 2013
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary diseaseMette Thomsen, Truls Sylvan Ingebrigtsen, Jacob Louis Marott, et al.
American Journal of Respiratory and Critical Care Medicine|September 22, 2012
Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationPeter Lange, Jacob Louis Marott, Jørgen Vestbo, et al.
The Lancet Regional Health. Europe|November 29, 2023
Impact of the metabolic syndrome on cardiopulmonary morbidity and mortality in individuals with lung function impairment: a prospective cohort study of the Danish general populationJacob Louis Marott, Truls Sylvan Ingebrigtsen, Yunus Çolak, et al.
BMJ Open Respiratory Research|June 11, 2019
COPD exacerbations: the impact of long versus short courses of oral corticosteroids on mortality and pneumonia: nationwide data on 67 000 patients with COPD followed for 12 monthsPradeesh Sivapalan, Truls Sylvan Ingebrigtsen, Daniel Bech Rasmussen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 13, 2023
Tobacco Exposure and Efficacy of Biologic Therapy in Patients With Severe Asthma: A Nationwide Study From the Danish Severe Asthma RegisterMarianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
ERJ Open Research|October 6, 2022
Complete response to anti-interleukin-5 biologics in a real-life setting: results from the nationwide Danish Severe Asthma RegisterMarianne Baastrup Soendergaard, Susanne Hansen, Anne-Sofie Bjerrum, et al.
BMJ Open Respiratory Research|September 29, 2023
Inhalation devices and inhaled corticosteroids particle size influence on severe pneumonia in patients with chronic obstructive pulmonary disease: a nationwide cohort studyChristian Kjer Heerfordt, Christian Rønn, Zitta Barrella Harboe, et al.
Thorax|August 27, 2021
Use of inhaled corticosteroids and risk of acquiring <i>Pseudomonas aeruginosa</i> in patients with chronic obstructive pulmonary diseaseJosefin Eklöf, Truls Sylvan Ingebrigtsen, Rikke Sørensen, et al.
Pageof 3